Stuart Loesch is a seasoned pharmaceutical executive with extensive experience in both the branded and consumer product sectors, with a particular focus on the allergy, asthma, and COPD therapeutic areas.
Prior to joining Transpire Bio, he served as President and Chief Commercial Officer at Intrommune Therapeutics. He began his career at GlaxoSmithKline, where he successfully led the launch of several innovative products for allergy, asthma, and COPD.
Throughout his career, he also held senior leadership roles at Altana Pharmaceuticals, Nycomed, Schering-Plough, Merck, Teva, and Meda Pharmaceuticals, where he led the North American business.